TRANSLACTATIONAL EXPOSURE OF F1 MOUSE PUPS TO SELENIUM

被引:2
作者
CHHABRA, SK [1 ]
RAO, AR [1 ]
机构
[1] JAWAHARLAL NEHRU UNIV,SCH LIFE SCI,CANC BIOL LAB,NEW DELHI 110067,INDIA
关键词
D O I
10.1016/0278-6915(94)90109-0
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
In an investigation of the modulation of certain neonatal xenobiotic-metabolizing enzymes in liver of mouse pups postnatally exposed to selenium through the transmammary route, sodium selenite was administered in drinking water to lactating dams at the dose levels of 1 or 5 ppm from day 1 of lactation and continued daily for 14 or 21 days. The higher dose of selenium was found to increase the hepatic acid-soluble sulfhydryl content significantly after 21 days of treatment in darns, their pups (P < 0.01) and in the 14-day-old male pups (P < 0.05). Cytochrome b(5) content decreased in the livers of dams that received 5 ppm selenium (P < 0.01) and in the F-1 pups (P < 0.01) translactationally exposed to selenium for 14 days. Cytochrome P-450 content decreased in darns and pups exposed to 5 ppm selenium for 14 days and either dose for 21 days (P < 0.01). Hepatic glutathione S-transferase decreased in the dam that had received 5 ppm selenium for 14 days (P < 0.05) and in the 14-day-old pups (P < 0.01). Glutathione reductase and glutathione peroxidase activities decreased in both dams and ups (P < 0.01). The overall suppression of neonatal hepatic detoxification enzymes demonstrates that selenium may have far-reaching consequences on neonatal growth, development and drug pharmacokinetics.
引用
收藏
页码:527 / 531
页数:5
相关论文
共 27 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]  
CARLBERG I, 1975, J BIOL CHEM, V250, P5475
[3]  
CHHABRA SK, 1992, THESIS JAWAHARLAL NE
[4]   SELENIUM IN FORAGE CROPS AND CANCER MORTALITY IN UNITED-STATES COUNTIES [J].
CLARK, LC ;
CANTOR, KP ;
ALLAWAY, WH .
ARCHIVES OF ENVIRONMENTAL HEALTH, 1991, 46 (01) :37-42
[5]  
COMBS GF, 1989, NUTRITION CANCER PRE, P389
[6]   TRANSFER OF PERSISTENT CHEMICALS IN MILK [J].
GALLENBERG, LA ;
VODICNIK, MJ .
DRUG METABOLISM REVIEWS, 1989, 21 (02) :277-317
[7]  
GREENWALD P, 1987, J NATL CANCER I, V79, P389
[8]  
HABIG WH, 1974, J BIOL CHEM, V249, P7130
[9]  
IP C, 1991, CANCER RES, V51, P596
[10]   INVERSE RELATIONSHIP BETWEEN CYTOCHROME-P-450 PHOSPHORYLATION AND COMPLEXATION WITH CYTOCHROME B5 [J].
JANSSON, I ;
EPSTEIN, PM ;
BAINS, S ;
SCHENKMAN, JB .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1987, 259 (02) :441-448